Cleveland Clinic research finds no benefit over placebo in ASSURE trial

Pharmaceutical RVX-208 failed to raise good cholesterol levels or reduce coronary plaque buildup more than placebo

2013-09-03

(Press-News.org) Monday, Sept. 3, 2013, Cleveland: Patients with coronary artery disease and low levels of "good cholesterol – or high-density lipoprotein (HDL) – who were treated with a drug designed to increase HDL levels and reduce coronary plaque build-up, experienced no better results than those treated with placebo, according to research conducted by the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).

The drug, RVX-208, induces the production of apolipoprotein A1 (apoA1), a major protein in HDL. Prior research has shown that higher levels of HDL are associated with improved coronary health, so the ASSURE trial was designed to test whether increased production of apoA1 with the drug RVX-208 would raise HDL levels and slow the progression of coronary atherosclerosis, or plaque build-up in the coronary arteries.

The results of the ASSURE (ApoA1 Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation) trial were presented at the European Society of Cardiology Congress 2013. ASSURE was a prospective, randomized, multicenter, double-blind clinical trial.

A team of researchers led by Stephen J. Nicholls, M.D., Ph.D., senior consultant to Cleveland Clinic's C5Research and Professor of Cardiology and Deputy Director at the South Australian Health & Medical Research Institute (SAHMRI) in Adelaide, Australia, used intravascular ultrasonography (IVUS) to assess the degree of coronary disease in study subjects at baseline and after 26 weeks on oral RVX-208 or placebo. IVUS is a medical imaging technology in which a small ultrasound probe is inserted via a catheter into an artery, allowing physicians to examine the inside of arteries via sonogram. The researchers also took baseline and 26-week measurements of apoA1 and HDL.

The primary endpoint – the change in percent atheroma volume (PAV), or the amount of artery volume taken up by disease – was not met. The PAV decreased by 0.4 percent in the RVX-208 group and 0.3 percent in the placebo group. Secondary IVUS endpoints – the change in total atheroma volume (TAV), or size of the disease, and the change in atheroma volume in the most severely diseased portion of the artery – also did not differ substantially between the RVX-208 group and the placebo group. Further, the biochemical endpoints of increased aopA1 and HDL levels, and decreased LDL, or bad cholesterol levels, also failed compared to placebo.

"Our results show that RVX-208 treatment did not result in any measurable incremental benefit on plaque regression for patients with coronary artery disease and low HDL cholesterol," said Nicholls. "The findings could reflect either a lack of efficacy of RVX-208, or the general inability to improve on the benefits produced by statins and other cardiovascular therapies."

All of the patients in ASSURE were being treated with atorvastatin or rosuvastatin, drugs shown in clinical trials to lower LDL levels.

"Ever since statins were approved more than 25 years ago, there has been an intensive, concerted effort in the scientific community to find an HDL-raising drug that will work in tandem with statins and improve cardiovascular outcomes," said Steven Nissen, M.D., Chairman of the ASSURE trial and Chairman of the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. "Unfortunately, that search must go on."

### ASSURE was an academically directed trial with funding and trial design input provided by Resverlogix Corp.

About Cleveland Clinic Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation's best hospitals in its annual "America's Best Hospitals" survey. More than 3,000 full-time salaried physicians and researchers and 11,000 nurses represent 120 medical specialties and subspecialties. The Cleveland Clinic health system includes a main campus near downtown Cleveland, more than 75 Northern Ohio outpatient locations, including 16 full-service Family Health Centers, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Cleveland Clinic Canada, and, currently under construction, Cleveland Clinic Abu Dhabi. In 2012, there were 5.1 million outpatient visits throughout the Cleveland Clinic health system and 157,000 hospital admissions. Patients came for treatment from every state and from more than 130 countries. Visit us at http://www.clevelandclinic.org. Follow us at http://www.twitter.com/ClevelandClinic.

Contacts: Wyatt DuBois, 216.904.3344, duboisw@ccf.org
Tora Vinci, 216.339.4277, vinciv@ccf.org

ELSE PRESS RELEASES FROM THIS DATE:

An easier way to control genes

2013-09-03

CAMBRIDGE, MA -- MIT researchers have shown that they can turn genes on or off inside yeast and human cells by controlling when DNA is copied into messenger RNA — an advance that could allow scientists to better understand the function of those genes. The technique could also make it easier to engineer cells that can monitor their environment, produce a drug or detect disease, says Timothy Lu, an assistant professor of electrical engineering and computer science and biological engineering and the senior author of a paper describing the new approach in the journal ACS ...

Young people at higher risk for stroke

2013-09-03

MAYWOOD, Il. -- Fifteen percent of the most common type of strokes occur in adolescents and young adults, and more young people are showing risk factors for such strokes, according to a report in the journal Neurology. Neurologist Jose Biller of Loyola University Medical Center is a co-author of the report, a consensus statement developed by the American Academy of Neurology. Between 532,000 and 852,000 persons ages 18 to 44 in the United States have had a stroke. U.S. hospital discharges for stroke among persons ages 15 to 44 increased 23-to-53 percent between 1995-1996 ...

Medicaid pays for nearly half of all births in the United States

2013-09-03

WASHINGTON, DC -- Medicaid paid for nearly half of the 3.8 million births in the United States in 2010 -- an amount that has been rising over time, according to a report out today. The study, published in the September 2013 issue of the peer-reviewed journal Women's Health Issues, offers the most comprehensive information to date on Medicaid financing of births in each of the 50 states and nationally. The new data will help researchers gauge the impact of health reform on maternal and child health, the authors say. Under the Affordable Care Act (ACA), some states are ...

Body weight influences both the physical and mental quality of life

2013-09-03

Scientists from the Institute of Health Economics and Health Care Management (IGM) and from the Institute of Epidemiology II (EPI II) discovered that weight gain leads to deterioration in physical health. Female study participants, however, experienced improved mental quality of life as their weight increased, a result that was observed even in women who were already overweight when the study began. For this study, Professor Dr Rolf Holle, Michael Laxy and their team evaluated data from the population-based longitudinal KORA study on the association between body weight ...

Facebook use by organizations during crises helps public image, MU study finds

2013-09-03

COLUMBIA, Mo. -- Social networking sites have become incredibly popular in recent years, with Facebook now ranking as the third most popular website in the U.S. With so many people spending so much time on Facebook, public relations professionals are using the site more and more to communicate to the public. Now, researchers at the University of Missouri School of Journalism have found that posting public relations information on Facebook during a time of crisis can improve the overall image of the organization that is experiencing the crisis. Seoyeon Hong, a doctoral ...

Blind mole-rats are resistant to chemically induced cancers

2013-09-03

CHAMPAIGN, Ill. — Like naked mole-rats (Heterocephalus gaber), blind mole-rats (of the genus Spalax) live underground in low-oxygen environments, are long-lived and resistant to cancer. A new study demonstrates just how cancer-resistant Spalax are, and suggests that the adaptations that help these rodents survive in low-oxygen environments also play a role in their longevity and cancer resistance. The findings are reported in the journal Biomed Central: Biology. "We've shown that, compared to mice and rats, blind mole-rats are highly resistant to carcinogens," said ...

Cleveland Clinic research finds blood pressure drug tends to slow coronary disease

2013-09-03

Tuesday, Sept. 3, 2013, Cleveland: Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research). The researchers found that the renin-inhibitor aliskiren tended to slow coronary disease progression and reduced the risk of death, stroke and heart attack in these patients by about 50 percent, compared to placebo, suggesting that patients with prehypertension may benefit ...

Brain study uncovers vital clue in bid to beat epilepsy

2013-09-03

People with epilepsy could be helped by new research into the way a key molecule controls brain activity during a seizure. Researchers have identified the role played by of a protein – called BDNF – and say the discovery could lead to new drugs that calm the symptoms of epileptic seizures. Scientists analysed the way cells communicate when the brain is most active – such as in epileptic seizures – when electrical signalling by the brain's neurons is increased. They found that the BDNF molecule – which is known to be released in the brain during seizures – blocks a ...

Birds choose sweet-smelling mates

2013-09-03

EAST LANSING, Mich. -- For most animals, scent is the instant messenger of choice for quickly exchanging personal profiles. Scientists, however, have long dismissed birds as odor-eschewing luddites that don't take advantage of scent-based communications. In a first-of-its-kind study, however, a Michigan State University researcher has demonstrated that birds do indeed communicate via scents, and that odor reliably predicts their reproductive success. The study appears in the current issue of Animal Behaviour and focuses on volatile compounds in avian preen secretions. Birds' ...

Study examines ways to restore immunity to chronic hepatitis C infection

2013-09-03

The hepatitis C virus hijacks the body's immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing the body to fight infection. The work, led by teams at The Research Institute at Nationwide Children's Hospital and Emory University, was published online Aug. 26 in the Proceedings of the National Academy of Sciences. Previous studies show that antibody treatments that inhibit the protein, called programmed cell death 1 (PD-1), can shrink tumors in ...

Cleveland Clinic research finds no benefit over placebo in ASSURE trial

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: